U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. VIMKUNYA
  1. Vaccines, Blood & Biologics

VIMKUNYA

STN: BLA 125820 
Proper Name: Chikungunya Vaccine, Recombinant
Tradename: VIMKUNYA
Manufacturer: Bavarian Nordic A/S
Indication:

  • For the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

Product Information

  • Package Insert - VIMKUNYA
  • Demographic Subgroup Information- Chikungunya Vaccine, Recombinant (VIMKUNYA)
    Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Back to Top